HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Osuga Selected Research

Catamenial pneumothorax

10/2020Extra-pelvic endometriosis: A review.
6/2018Thoracic endometriosis syndrome: Comparison between catamenial pneumothorax or endometriosis-related pneumothorax and catamenial hemoptysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Osuga Research Topics

Disease

92Endometriosis
11/2022 - 03/2003
58Neoplasms (Cancer)
07/2022 - 01/2002
25Inflammation (Inflammations)
07/2022 - 05/2003
24Endometrial Neoplasms (Endometrial Cancer)
03/2022 - 12/2005
16Leiomyoma (Uterine Fibroids)
01/2022 - 12/2005
15Pre-Eclampsia (Preeclampsia)
01/2022 - 05/2003
13Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 01/2013
12Adenomyosis
01/2022 - 03/2006
12Pain (Aches)
01/2022 - 09/2011
11Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 01/2016
10Hemorrhage
01/2022 - 01/2008
10Carcinoma (Carcinomatosis)
11/2020 - 05/2016
10Dysmenorrhea (Menstrual Pain)
04/2020 - 01/2013
8Infertility (Sterility)
01/2020 - 01/2012
7Ascites
03/2022 - 01/2016
7Metrorrhagia (Spotting)
01/2022 - 02/2013
7Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
11/2021 - 05/2014
6Carcinogenesis
01/2022 - 12/2014
6Hypoxia (Hypoxemia)
01/2022 - 10/2003
5Pelvic Pain
01/2022 - 10/2014
5Uterine Hemorrhage (Uterine Bleeding)
10/2020 - 11/2010
5Premature Birth (Birth, Premature)
08/2020 - 11/2013
4Neoplasm Metastasis (Metastasis)
07/2022 - 01/2014
4Cysts
03/2022 - 03/2003
4Fibrosis (Cirrhosis)
01/2022 - 10/2005
4Menorrhagia
01/2021 - 01/2019
4Body Weight (Weight, Body)
10/2020 - 04/2019
3Fever (Fevers)
01/2022 - 07/2014
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 10/2019
3Pregnancy Complications
01/2022 - 08/2014
3Amenorrhea
09/2021 - 04/2016
3Pneumothorax
10/2020 - 09/2015
3Premature Obstetric Labor (Premature Labor)
06/2015 - 03/2013
2Disease Progression
07/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
12/2020 - 08/2002
17dienogestFDA Link
10/2020 - 05/2008
15CytokinesIBA
01/2022 - 08/2008
14Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2021 - 08/2002
14Progestins (Progestagens)IBA
01/2020 - 04/2007
13Estrogens (Estrogen)FDA Link
11/2019 - 01/2002
12Messenger RNA (mRNA)IBA
01/2021 - 11/2005
10Oral ContraceptivesIBA
03/2022 - 05/2011
8Hormones (Hormone)IBA
01/2022 - 01/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 05/2003
8Interleukin-8 (Interleukin 8)IBA
10/2020 - 10/2003
8Estradiol (Delestrogen)FDA LinkGeneric
08/2020 - 12/2006
7Leuprolide (Lupron)FDA LinkGeneric
01/2022 - 01/2019
7InterleukinsIBA
01/2020 - 10/2003
6Cisplatin (Platino)FDA LinkGeneric
03/2022 - 06/2015
6Pharmaceutical PreparationsIBA
01/2022 - 01/2019
6Histones (Histone)IBA
01/2022 - 01/2019
6relugolixIBA
01/2022 - 01/2019
6Histone MethyltransferasesIBA
11/2021 - 06/2017
6EnzymesIBA
01/2020 - 10/2004
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2018 - 02/2009
5Estrogen ReceptorsIBA
11/2022 - 01/2013
5LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
01/2022 - 11/2005
5Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 01/2013
5Therapeutic UsesIBA
08/2020 - 01/2008
5Interleukin-17 (Interleukin 17)IBA
10/2019 - 03/2008
5Biomarkers (Surrogate Marker)IBA
10/2019 - 03/2014
5Proteinase-Activated ReceptorsIBA
01/2012 - 06/2005
5AdiponectinIBA
03/2010 - 10/2005
4LigandsIBA
01/2021 - 02/2009
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 01/2008
4ProgesteroneFDA LinkGeneric
01/2021 - 12/2008
4Small Interfering RNA (siRNA)IBA
04/2020 - 10/2016
4Interleukin-6 (Interleukin 6)IBA
10/2018 - 07/2011
4ResveratrolIBA
10/2016 - 03/2014
4Interleukin-4 (Interleukin 4)IBA
04/2013 - 08/2008
4ThrombinFDA Link
10/2012 - 08/2003
3Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 06/2017
3Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 07/2014
3ulipristal acetateFDA Link
01/2022 - 01/2021
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2014
3ThrombomodulinIBA
01/2022 - 01/2021
3LipopolysaccharidesIBA
01/2021 - 12/2015
3Hemoglobins (Hemoglobin)IBA
10/2020 - 08/2018
3Sirtuin 1IBA
04/2020 - 08/2012
3Indicators and Reagents (Reagents)IBA
04/2019 - 05/2010
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 03/2014
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2018 - 08/2015
3SurvivinIBA
11/2018 - 01/2016
3Oxygen (Dioxygen)IBA
01/2017 - 11/2004
3Aromatase (CYP19)IBA
12/2016 - 04/2013
3Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
04/2016 - 04/2007
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2014 - 01/2013
3Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2012 - 05/2003
3OsteoprotegerinIBA
03/2010 - 10/2004
3MidkineIBA
03/2010 - 04/2005
2Mitogen-Activated Protein KinasesIBA
11/2022 - 11/2004

Therapy/Procedure

35Therapeutics
03/2022 - 04/2007
17Hysterectomy
11/2022 - 03/2006
12Drug Therapy (Chemotherapy)
03/2022 - 01/2011
9Uterine Myomectomy
10/2018 - 11/2009
5Conservative Treatment
07/2022 - 04/2007
5Cesarean Section (Caesarean Section)
05/2022 - 11/2010
4Aftercare (After-Treatment)
02/2022 - 10/2017
3Oral Administration
04/2021 - 09/2020
2Adjuvant Chemotherapy
07/2022 - 11/2015